Summary
Elevance Health, Inc. (ELV) reported solid financial results for the quarter ending June 29, 2023, demonstrating continued growth and operational strength. Total revenues increased by 12.7% year-over-year for the quarter, driven by strong performance in its Health Benefits segment and growth in CarelonRx. Net income saw a healthy increase of 13.6% compared to the prior year's quarter, reflecting improved operating gains and efficient cost management. The company also reported a significant increase in operating cash flow, highlighting its ability to generate substantial cash from its core operations. Membership continued to grow, particularly in Medicaid and Medicare Advantage, underscoring the company's expanding reach in key government programs. Key strategic initiatives are progressing, including the pending acquisition of Blue Cross and Blue Shield of Louisiana, which is expected to further enhance the company's market position. Management highlighted prudent capital allocation, including ongoing share repurchases and dividend payments, reinforcing its commitment to shareholder value. Despite the dynamic healthcare landscape, Elevance Health has demonstrated resilience and strategic execution, positioning it favorably for future growth.
Financial Highlights
53 data points| Revenue | $43.67B |
| Cost of Revenue | $4.33B |
| Gross Profit | $39.34B |
| SG&A Expenses | $4.82B |
| Operating Income | $2.63B |
| Interest Expense | $261.00M |
| Net Income | $1.85B |
| EPS (Basic) | $7.83 |
| EPS (Diluted) | $7.79 |
| Shares Outstanding (Basic) | 236.60M |
| Shares Outstanding (Diluted) | 237.80M |
Key Highlights
- 1Total operating revenue increased by 12.7% to $43.4 billion for the three months ended June 30, 2023, compared to the prior year.
- 2Shareholders' net income increased by 13.2% to $1.85 billion for the three months ended June 30, 2023, compared to the prior year.
- 3Diluted EPS rose to $7.79 for the three months ended June 30, 2023, an increase of 15.8% year-over-year.
- 4Total medical membership grew by 2.0% to approximately 48 million as of June 30, 2023, driven by Medicaid, BlueCard sales, and Medicare Advantage.
- 5Operating cash flow for the first six months of 2023 was $8.4 billion, a substantial increase from $5.0 billion in the prior year.
- 6The company is proceeding with the acquisition of Blue Cross and Blue Shield of Louisiana, expected to close by year-end 2023.
- 7Elevance Health repurchased $1.27 billion of its common stock in the first six months of 2023.